The Food and Drug Administration issued a notice on Friday classifying its recall of the Boston Scientific Accolade pacemaker devices as the most serious type of recall. To date, 832 injuries and ...

Boston Scientific (BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment.

Boston Scientific has reached an agreement to acquire SoniVie, a medical device company developing the TIVUS Intravascular Ultrasound System, an investigational technology aimed at treating ...

Boston Scientific has agreed to buy the rest of privately held medical-device company SoniVie for an initial $360 million in a deal that expands its portfolio of interventional cardiology therapies.

RBC Capital Markets also lifted its price target to $116, citing Boston Scientific's strong initial guide for 2025 and solid execution as key drivers. Truist Securities echoed these sentiments ...